Đang chuẩn bị liên kết để tải về tài liệu:
The impact of high-flow nasal cannula oxygen therapy on exercise capacity in fibrotic interstitial lung disease: A proof-ofconcept randomized controlled crossover trial
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Patients with fibrotic interstitial lung disease (FILD) often experience gas exchange abnormalities and ventilatory limitations, resulting in reduced exercise capacity. High-flow nasal cannula (HFNC) oxygen therapy is a novel treatment, whose physiological beneficial effects have been demonstrated in various clinical settings. |